| Product Code: ETC7736603 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Japan saw steady import shipments of dog and cat drug compounds mainly from Germany, Switzerland, USA, Italy, and Metropolitan France. The low Herfindahl-Hirschman Index (HHI) indicates a diverse market with no dominant player. Despite a negative compound annual growth rate (CAGR) of -5.32% from 2020 to 2024, the slight improvement in the growth rate of -3.46% from 2023 to 2024 suggests a potential stabilization in the market. The consistent import flow from these top exporting countries highlights the demand for specialized medications for pets in Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Dog and Cat Drug Compounding Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Dog and Cat Drug Compounding Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Dog and Cat Drug Compounding Market - Industry Life Cycle |
3.4 Japan Dog and Cat Drug Compounding Market - Porter's Five Forces |
3.5 Japan Dog and Cat Drug Compounding Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Japan Dog and Cat Drug Compounding Market Revenues & Volume Share, By Dosages Form, 2021 & 2031F |
3.7 Japan Dog and Cat Drug Compounding Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Dog and Cat Drug Compounding Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
4 Japan Dog and Cat Drug Compounding Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership in Japan |
4.2.2 Rising awareness about personalized pet healthcare |
4.2.3 Growing demand for specialty medications for pets |
4.2.4 Advancements in veterinary medicine and technology |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements for drug compounding |
4.3.2 Limited availability of skilled professionals in drug compounding for pets |
4.3.3 High costs associated with developing and producing compounded medications for pets |
5 Japan Dog and Cat Drug Compounding Market Trends |
6 Japan Dog and Cat Drug Compounding Market, By Types |
6.1 Japan Dog and Cat Drug Compounding Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Anti-infective Drugs, 2021- 2031F |
6.1.4 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Anti-inflammatory Drugs, 2021- 2031F |
6.1.5 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By CNS Agents, 2021- 2031F |
6.1.6 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By GI Drugs, 2021- 2031F |
6.1.7 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Dog and Cat Drug Compounding Market, By Dosages Form |
6.2.1 Overview and Analysis |
6.2.2 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Tablets & Capsules, 2021- 2031F |
6.2.3 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Powder, 2021- 2031F |
6.2.4 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Solution, 2021- 2031F |
6.2.5 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Dog and Cat Drug Compounding Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.5 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Dog and Cat Drug Compounding Market, By Animal Type |
6.4.1 Overview and Analysis |
6.4.2 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Dog, 2021- 2031F |
6.4.3 Japan Dog and Cat Drug Compounding Market Revenues & Volume, By Cat, 2021- 2031F |
7 Japan Dog and Cat Drug Compounding Market Import-Export Trade Statistics |
7.1 Japan Dog and Cat Drug Compounding Market Export to Major Countries |
7.2 Japan Dog and Cat Drug Compounding Market Imports from Major Countries |
8 Japan Dog and Cat Drug Compounding Market Key Performance Indicators |
8.1 Number of veterinary clinics offering drug compounding services for dogs and cats in Japan |
8.2 Adoption rate of personalized medication solutions for pets in the market |
8.3 Percentage of pet owners opting for customized compounded medications for their pets |
9 Japan Dog and Cat Drug Compounding Market - Opportunity Assessment |
9.1 Japan Dog and Cat Drug Compounding Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Japan Dog and Cat Drug Compounding Market Opportunity Assessment, By Dosages Form, 2021 & 2031F |
9.3 Japan Dog and Cat Drug Compounding Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Dog and Cat Drug Compounding Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
10 Japan Dog and Cat Drug Compounding Market - Competitive Landscape |
10.1 Japan Dog and Cat Drug Compounding Market Revenue Share, By Companies, 2024 |
10.2 Japan Dog and Cat Drug Compounding Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here